SecBot SecBot
PRESS-RELEASE ·Filed Apr 30, 2026

SYK

Stryker Corporation
BEARISH
Impact 8/10
Horizonimmediate Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

The massive GAAP EPS miss and weak organic growth (2.4% vs 8.0-9.5% guidance) create significant credibility risk. The maintained guidance implies a dramatic acceleration in the remaining three quarters, watch for pre-announcements or guidance cuts. The cyber incident impact and Spinal Implants collapse warrant deeper investigation. Expect negative price reaction at open.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$293.78
T+0 close · Apr 30, 2026 · via day close
Latest settled
+14.62%
T+60 · $336.74
Vs SPY
+12.07%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 1 $293.78entry
  2. T+1 · 7mo ago −0.97%α −0.62% · $290.94
  3. T+5 · 6mo ago −2.83%α −5.18% · $285.47
  4. T+20 · 6mo ago +1.86%α −3.41% · $299.24
  5. T+60 · 4mo ago +14.62%α +12.07% · $336.74

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Stryker reported Q1 2026 GAAP EPS of $1.93 (vs consensus $2.98, a 35.2% miss) and adjusted EPS of $2.60 (down 8.5% YoY). Revenue of $6.02B missed the $6.33B consensus by 4.9%, with organic sales growth of only 2.4%, well below the 8.0-9.5% full-year guidance. The company maintained its full-year guidance despite the weak quarter, citing a quick recovery from a cyber incident, but the headline numbers represent a significant miss on both top and bottom lines.

Key Financial Metrics

EPS
$1.93
est $2.98 · -35.2%
Revenue
$6.0B
est $6.3B · -4.9% · +2.6% YoY
Rating
strong miss
Guidance
8.0% to 9.5% organic growth
maintained
Free Cash Flow
$415.0M
Gross Margin
63.3%

Key Facts

  • Reported GAAP EPS of $1.93 missed consensus of $2.98 by 35.2%
  • Adjusted EPS of $2.60 declined 8.5% YoY
  • Revenue of $6.02B missed consensus of $6.33B by 4.9%
  • Organic net sales growth of only 2.4% vs full-year guidance of 8.0-9.5%
  • Adjusted operating margin contracted 180 bps to 21.1%
  • Full-year 2026 guidance maintained: organic sales growth 8.0-9.5%, adjusted EPS $14.90-$15.10
  • Spinal Implants revenue collapsed 98.9% YoY to $2M (likely due to Inari acquisition restructuring)
  • Vascular segment grew 27.5% reported, but Medical segment declined 4.6%

Financial Impact

EPS miss of $1.05 vs consensus on GAAP basis; revenue miss of ~$310M; adjusted EPS down 8.5% YoY

epsrevenueoperating marginorganic growth

Risk Factors

  • Full-year guidance appears unrealistic given Q1 organic growth of 2.4% vs 8.0-9.5% target
  • Cyber incident may have lingering operational impacts beyond Q1
  • Spinal Implants business effectively zeroed out, restructuring risk
  • Adjusted operating margin compression of 180 bps signals cost headwinds

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
75% bullish (36 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3285455

Track record

29 reports on SYK

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +23.40% at T+20 after the Oct 7, 2026 report. 6 of 10 went positive at some point.

Filters
  1. Nov 12, 20266d ago Court Ruling Neutral 3/10 Entry $309.64 Now $310.72 +0.35% settles Dec 14
  2. Nov 9, 20268d ago 8-K Neutral 2/10 Entry $324.29 Now $310.72 −4.18% settles Dec 9
  3. Nov 5, 202612d ago 144 Neutral 3/10 Entry $325.87 Now $310.72 −4.65% settles Dec 7
  4. Nov 4, 202613d ago S-3ASR Neutral 3/10 Entry $335.08 Now $310.72 −7.27% settles Dec 4
  5. Nov 3, 202614d ago Institutional Cluster Mixed 3/10 Entry $310.55 Now $310.72 +0.05% settles Dec 2
  6. Oct 29, 202619d ago 8-K Bearish 6/10 No price data
  7. Oct 29, 202619d ago Press Release Bearish 6/10 Entry $291.86 Now $310.72 −6.46% settles Nov 30
  8. Oct 26, 202622d ago Press Release Neutral 4/10 Entry $306.13 Now $310.72 +1.50% settles Nov 23
  9. Oct 20, 202629d ago PTAB Trial Bearish 5/10 Entry $297.60 Now $310.72 −4.41% settles Nov 18
  10. Oct 7, 20265w ago ANALYST-UPGRADE Bullish 4/10 Entry $275.25 to $339.65 Now $310.72 +12.89% ▲ +23.40% +24.74% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Thu (12h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026